In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

A new book shows how Johnson & Johnson has pushed misleading narratives and suppressed inconvenient findings to sell its ...

The 19-year-old student opened up about her family's experience of the disaster in an essay written for Yale University's ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Joe Biden suddenly diagnosed with cancer. What's going on? DR. JAMIN BRAHMBHATT, UROLOGIST, ORLANDO HEALTH: One of the biggest side effects that I see in my patients that get these hormone treatments ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

Surgeons in southern California successfully completed the world's first-ever human bladder transplant on 41-year-old Oscar ...

Revolutionizing Alzheimer's care, Zunveyl minimizes GI and sleep side effects. Discover its market potential and why it's ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.